Ifp Advisors, Inc Coh Bar, Inc. Transaction History

Ifp Advisors, Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 06, 2021	SELL	$0.96 - $1.62 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$1.09 - $1.49 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$1.26 - $2.02 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$0.9 - $1.54 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$0.87 - $2.08 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$1.08 - $4.0 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$1.01 - $2.74 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	BUY	$1.2 - $2.34 $0 - $0	0 New	0 $0
Q3 2019 Nov 07, 2019	BUY	$1.3 - $1.76 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	SELL	$2.95 - $4.16 $11,947 - $16,848	-4,050 Closed	0 $0
Q4 2018 Jan 23, 2019	BUY	$2.97 - $4.52 $8,999 - $13,695	3,030 Added 297.06%	4,050 $12,000
Q3 2018 Oct 25, 2018	BUY	$4.13 - $6.84 $4,130 - $6,840	1,000 Added 5000.0%	1,020 $0
Q2 2018 Aug 07, 2018	SELL	$4.44 - $10.4 $6,660 - $15,600	-1,500 Reduced 98.68%	20 $0
Q1 2018 May 09, 2018	BUY	$4.85 - $6.92 $7,371 - $10,518	1,520 New	1,520 $0

1.14K

Ticker CWBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,906,940
Market Cap $1.57M
Description
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.